APP and Alzheimer disease: In another study, the levels of CD3, CD4, CD45, CD64, β-APP-cleaving enzyme 1 (BACE1), amyloid-β (Aβ), and APP in CSF-EVs were analyzed by flow cytometry in AD patients compared to controls.